BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 24, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

June 7, 2005

View Archived Issues

New vitamin D analogue ZK-156979 possesses strong immunosuppressive activity

Read More

BAY-58-2667: a promising therapy for severe pulmonary hypertension

Read More

Dynavax presents results of a clinical trial with 1018-ISS in allergic asthma

Read More

Ramelteon does not impair respiration in patients with COPD or sleep apnea

Read More

Clinical evidence supports the use of ciclesonide in asthma

Read More

Update on the effects of roflumilast in asthma, COPD and emphysema

Read More

Herstatin: a new endogenous insulin sensitizer

Read More

First synthetic CRTH2 agonist identified and tested

Read More

CP-2117: Novel 2-methoxyestradiol analogue for asthma therapy

Read More

Effects of TZP-101 at gastrointestinal and pituitary/hypothalamic level in rats

Read More

TH-9507 reported to improve serum lipid parameters

Read More

A new study to assess the neuroprotective effects of piclozotan in acute ischemic stroke

Read More

U.S. approval for Glumetza

Read More

Not approvable letter for Zimycan

Read More

Revatio approved for PAH

Read More

Celgene studying lenalidomide for complex regional pain syndrome type 1

Read More

Somatropin studied in phase II trial for pediatric Crohn's disease

Read More

Preclinical studies suggest use for Cardio Vascu-Grow in stroke patients

Read More

New phase IIb dose-finding study for obesity drug AOD-9604

Read More

Exelixis and Genentech establish new collaboration

Read More

Intra-Cellular Therapies licenses preclinical CNS compounds from BMS

Read More

Codexis receives milestone payment from Pfizer collaboration

Read More

Neurion receives SBIR grant to support antianxiety drug development

Read More

HuMax-CD20 effective in killing tumor cells with low levels of CD20

Read More

Allon's AL-108 and AL-208 cross blood-brain barrier in preclinical studies

Read More

DiaKine acquires IND application for lisofylline

Read More

New River reviews pipeline

Read More

Taxol approved for endometrial cancer in Japan

Read More

Eculizumab, an anti-C5 antibody, has therapeutic potential in severe asthma

Read More

New treatments for cancer covered in recent patents

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing